Rick Bright arrives to testify before the House Energy and Commerce Subcommittee on Health on May 14, 2020, in Washington, DC. (Greg Nash, POOL/AFP via Getty Images)

Rick Bright de­tails mis­man­aged pan­dem­ic re­sponse, warns of drugs, vac­cine sup­ply prob­lems down the road; HHS push­es back

In wide-rang­ing con­gres­sion­al tes­ti­mo­ny, the oust­ed head of an agency at the cen­ter of the fed­er­al gov­ern­ment’s Covid-19 vac­cine and treat­ment re­sponse crit­i­cized the Trump ad­min­is­tra­tion for a slow-foot­ed fed­er­al re­sponse that could re­sound through­out the course of the pan­dem­ic.

“I be­lieve we could have done bet­ter,” Rick Bright, for­mer chief of the Bio­med­ical Ad­vanced Re­search and De­vel­op­ment Au­thor­i­ty (BAR­DA), told a House sub­com­mit­tee. “We don’t have the right lead­er­ship for this re­sponse and we don’t have the right plan for this re­sponse.”

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.